| Literature DB >> 25525422 |
Har Lal Singh1, Jangbhadur Singh1.
Abstract
New series of organoEntities:
Year: 2014 PMID: 25525422 PMCID: PMC4265522 DOI: 10.1155/2014/716578
Source DB: PubMed Journal: Bioinorg Chem Appl Impact factor: 7.778
Analytical and physical data of the organotin(IV) complexes.
| C. number | Reactants | Molar ratio | Products & colour | M.P. °C (d) | Yield (%) | Elemental analysis found (calcd.) |
Mol. Wt. | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Metal | Ligands | %Sn | %C | %H | %N | ||||||
| Bu2Sn(L1)2 | Bu2SnO | C17H14N2O3 | 1 : 2 | C42H44N4O6Sn | 164 | 94 | 14.35(14.49) | 61.30(61.55) | 5.44(5.41) | 6.72(6.84) | 824.55(819.53) |
|
| |||||||||||
| Bu2Sn(L2)2 | Bu2SnO | C14H16N2O3 | 1 : 2 | C36H48N4O6Sn | 262 | 79.14 | 15.84(15.80) | 57.50(57.54) | 6.38(6.44) | 7.56(7.46) | 742.19(751.50) |
|
| |||||||||||
| Bu2Sn(L3)2 | Bu2SnO | C10H8N2O3 | 1 : 2 | C28H32N4O6Sn | 174 | 76.81 | 18.43(18.57) | 52.45(52.61) | 5.00(5.05) | 8.65(8.76) | 630.88(639.29) |
|
| |||||||||||
| Bu2Sn(L4)2 | Bu2SnO | C17H13ClN2O3 | 1 : 2 | C42H42Cl2N4O6Sn | 210 | 72.39 | 13.03(13.36) | 56.84(56.78) | 4.73(4.76) | 6.39(6.31) | 872.54(888.42) |
|
| |||||||||||
| Bu2Sn(L5)2 | Bu2SnO | C14H15ClN2O3 | 1 : 2 | C36H46Cl2N4O6Sn | 270 | 68.29 | 14.34(14.47) | 52.59(52.71) | 5.60(5.65) | 6.70(6.83) | 831.57(820.38) |
|
| |||||||||||
| Bu2Sn(L6)2 | Bu2SnO | C10H7ClN2O3 | 1 : 2 | C28H30Cl2N4O6Sn | 180–184 | 71.72 | 16.84(16.76) | 47.41(47.49) | 4.25(4.27) | 7.85(7.91) | 716.67(708.18) |
Scheme 1Representative equation illustrating the formation of dibutyltin(IV) complexes.
Important IR spectral data (cm−1) of Schiff bases and their corresponding organotin(IV) complexes.
| Compounds |
|
|
|
|
| Δ |
|
|
|
|---|---|---|---|---|---|---|---|---|---|
| L1H | 3090–2740 br | 1620 s | 1728 s | — | — | — | — | — | — |
| Bu2Sn(L1)2 | — | 1610 s | 1722 s | 1590 vs | 1325 s | 265 | 540 w | 430 m | 622 m |
| L2H | 3100–2740 br | 1625 s | 1730 s | — | — | — | — | — | — |
| Bu2Sn(L2)2 | — | 1612 s | 1726 s | 1605 m | 1333 m | 272 | 545 m | 426 s | 640 m |
| L3H | 3090–2750 br | 1630 s | 1720 s | — | — | — | — | — | — |
| Bu2Sn(L3)2 | — | 1616 s | 1722 s | 1601 s | 1332 m | 268 | 552 m | 425 m | 630 m |
| L4H | 3110–2750 br | 1622 s | 1735 s | — | — | — | — | — | — |
| Bu2Sn(L4)2 | — | 1605 s | 1732 s | 1608 s | 1330 m | 278 | 545 s | 420 w | 635 m |
| L5H | 3080–2730 br | 1630 s | 1735 s | — | — | — | — | — | — |
| Bu2Sn(L5)2 | — | 1612 s | 1734 s | 1595 vs | 1326 s | 269 | 540 w | 425 w | 625 m |
| L6H | 3109–2730 br | 1622 s | 1725 s | — | — | — | — | — | — |
| Bu2Sn(L6)2 | — | 1610 s | 1728 s | 1610 vs | 1340 vs | 270 | 544 w | 432 m | 632 m |
br: broad, vs: very sharp, v: sharp, m: medium, and w: weak.
1H NMR spectral dataa of the ligands and their corresponding organotin(IV) complexes.
| Compounds | Chemical Shift ( |
|---|---|
| L1H | 11.50 (s, 1H, COO |
|
| |
| Bu2Sn(L1)2 | 4.21 (s, 1H, N–C |
|
| |
| L2H | 11.39 (s, 1H, COO |
|
| |
| Bu2Sn(L2)2 | 3.98 (d, 1H, N–C |
|
| |
| L3H | 11.28 (s, 1H, COOH), 4.30 (s, 2H, N–C |
|
| |
| Bu2Sn(L3)2 | 4.38 (s, 2H, N–C |
|
| |
| L4H | 11.42 (s, 1H, COO |
|
| |
| Bu2Sn(L4)2 | 4.02 (t, 1H, N–C |
|
| |
| L5H | 11.42 (s, 1H, COO |
|
| |
| Bu2Sn(L5)2 | 4.01 (d, 1H, N–C |
|
| |
| L6H | 11.35 (s, 1H, COO |
|
| |
| Bu2Sn(L6)2 | 4.40 (s, 2H, N–C |
aChemical shift (δ) in ppm: Multiplicity is given as: s = singlet, d = doublet, t = triplet, q = quartet, m = complex pattern, br = broad.
13C NMR spectral data of the ligands and their corresponding organotin(IV) complexes.
| Compounds | Chemical shift in ( | |||||
|---|---|---|---|---|---|---|
| COOH | CH | C=N | CH2/CH3 | Aromatic carbons | Sn– | |
| L1H | 176.8 | 67.8 | 163.4 | 38.2 | 149.2, 135.8, 133.0, 128.6, 127.5, 126.3, 124.6, 122.9, 120.1 | — |
|
| ||||||
| Bu2Sn(L1)2 | 185.4 | 65.7 | 155.2 | 39.4 | 150.0, 136.1, 132.6, 128.2, 127.1, 126.5, 124.4, 123.3, 120.2 | C- |
|
| ||||||
| L2H | 178.5 | 65.7 | 162.4 | 16.3, 21.3 | 145.8, 133.2, 130.5, 126.2, 124.0, 119.3 | — |
|
| ||||||
| Bu2Sn(L2)2 | 184.9 | 66.2 | 154.6 | 17.4, 22.1 | 146.2, 132.9, 130.8, 126.54, 124.3, 120.1 | C- |
|
| ||||||
| L3H | 176.1 | — | 163.6 | 52.4 | 148.5, 131.0, 129.8, 125.3, 122.9, 119.1 | — |
|
| ||||||
| Bu2Sn(L3)2 | 183.7 | — | 154.5 | 58.3 | 149.0, 132.5, 129.6, 125.7, 123.4, 119.6 | C- |
|
| ||||||
| L4H | 178.5 | 65.7 | 162.4 | 39.1 | 150.2, 136.1, 132.8, 129.5, 127.3, 126.4, 123.2, 122.4, 119.8 | — |
|
| ||||||
| Bu2Sn(L4)2 | 184.5 | 66.2 | 154.5 | 38.7 | 149.5, 135.7, 132.1, 130.4, 126.9, 126.2, 123.5, 122.1, 120.3 | C- |
|
| ||||||
| L5H | 177.5 | 66.2 | 163.1 | 17.3, 20.5 | 147.7, 132.8, 131.3, 126.6, 123.8, 120.3 | — |
|
| ||||||
| Bu2Sn(L5)2 | 184.1 | 67.4 | 153.8 | 18.0, 20.2 | 148.1, 132.4, 129.7, 126.5, 124.0, 120.2 | C- |
|
| ||||||
| L6H | 176.9 | — | 162.9 | 55.4 | 149.5, 132.8, 128.9, 125.7, 123.0, 120.3 | — |
|
| ||||||
| Bu2Sn(L6)2 | 182.8 | — | 155.4 | 56.1 | 148.2, 133.1, 128.5, 125.8, 122.7, 120.5 | C- |
Figure 1Structure of diorganotin(IV) complexes.
X-ray powder diffraction data for compounds (L1H) and (L2H).
| S. number | 2 | “ | Intensity (count) | FWHM |
|
|---|---|---|---|---|---|
| L1H | |||||
| 1 | 13.517 | 6.54547 | 385.6 | 0.5425 | 25.381 |
| 2 | 14.936 | 5.92655 | 482.3 | 0.4308 | 31.912 |
| 3 | 16.873 | 5.25031 | 216.5 | 0.7307 | 18.770 |
| 4 | 21.492 | 4.13128 | 323.9 | 0.7307 | 18.643 |
| 5 | 22.046 | 4.02874 | 453.9 | 0.6139 | 22.169 |
| 6 | 22.521 | 3.94474 | 289.4 | 0.6139 | 22.151 |
| 7 | 24.025 | 3.70113 | 301.8 | 0.6139 | 22.091 |
| 8 | 24.805 | 3.58649 | 162.8 | 0.6139 | 22.059 |
| 9 | 25.067 | 3.54964 | 205.2 | 0.6139 | 22.047 |
| 10 | 26.359 | 3.37851 | 150.7 | 0.6139 | 21.991 |
| 11 | 27.324 | 3.26131 | 228.2 | 0.486 | 27.722 |
| 12 | 28.440 | 3.13581 | 217.5 | 0.7166 | 18.756 |
| 13 | 32.024 | 2.79258 | 112.5 | 0.7166 | 18.598 |
|
| |||||
| L2H | |||||
| 1 | 11.495 | 7.69156 | 128 | 0.3461 | 39.860 |
| 2 | 13.137 | 6.73368 | 236.3 | 0.3806 | 36.191 |
| 3 | 14.870 | 5.95279 | 807.9 | 0.2844 | 48.343 |
| 4 | 16.683 | 5.30969 | 228.6 | 0.3597 | 38.139 |
| 5 | 21.263 | 4.17518 | 222.4 | 0.3597 | 37.885 |
| 6 | 22.035 | 4.03068 | 286.1 | 0.5986 | 22.736 |
| 7 | 23.706 | 3.75021 | 263.9 | 0.5544 | 24.476 |
| 8 | 24.902 | 3.57273 | 521.9 | 0.3499 | 38.695 |
| 9 | 26.232 | 3.39454 | 156.1 | 0.3499 | 38.593 |
| 10 | 27.114 | 3.28608 | 717.3 | 0.2874 | 46.899 |
| 11 | 31.637 | 2.82587 | 144.2 | 0.4665 | 28.597 |
| 12 | 37.570 | 2.3921 | 84.3 | 0.6166 | 21.289 |
* D: crystallite size (in Å) and d: lattice spacing.
Figure 2X-ray powder diffraction patterns of the compound [L1H].
Figure 3X-ray powder diffraction patterns of the compound [L2H].
Important bond lengths of compound [Bu2Sn(L2)2].
| S. number | Atoms | Actual (Å) | Optimal (Å) |
|---|---|---|---|
| 1 | Sn(1)–C(44) | 2.2339 | 2.1620 |
| 2 | Sn(1)–C(47) | 2.2064 | 2.1620 |
| 3 | N(9)–Sn(1) | 2.1050 | — |
| 4 | N(5)–Sn(1) | 2.1010 | — |
| 5 | Sn(1)–C(44) | 2.2339 | 2.1620 |
| 6 | Sn(1)–O(6) | 2.0644 | — |
| 7 | O(6)–C(7) | 1.3666 | 1.3380 |
| 8 | Sn(1)–O(2) | 2.0581 | — |
| 9 | O(2)–C(3) | 1.3639 | 1.3380 |
| 10 | Sn(1)–C(47) | 2.2064 | 2.1620 |
| 11 | N(5)–C(14) | 2.1680 | 1.2600 |
| 12 | C(4)–N(5) | 1.4923 | 1.4700 |
Important bond angles of compound [Bu2Sn(L2)2].
| S. number | Atoms | Actual (°) |
|---|---|---|
| 1 | C(47)–Sn(1)–C(44) | 117.1540 |
| 2 | C(47)–Sn(1)–N(5) | 85.7227 |
| 3 | C(47)–Sn(1)–N(9) | 124.3910 |
| 4 | C(47)–Sn(1)–O(6) | 68.5077 |
| 5 | C(47)–Sn(1)–O(2) | 141.0197 |
| 6 | C(44)–Sn(1)–N(5) | 80.4837 |
| 7 | C(44)–Sn(1)–N(9) | 78.7094 |
| 8 | C(44)–Sn(1)–O(6) | 138.6752 |
| 9 | C(44)–Sn(1)–O(2) | 88.6745 |
| 10 | N(5)–Sn(1)–N(9) | 148.9524 |
| 11 | N(5)–Sn(1)–O(6) | 139.5356 |
| 12 | N(5)–Sn(1)–O(2) | 69.4566 |
| 13 | N(9)–Sn(1)–O(6) | 67.5865 |
| 14 | N(9)–Sn(1)–O(2) | 87.2268 |
| 15 | O(6)–Sn(1)–O(2) | 112.0005 |
Figure 43D molecular structure of Bu2Sn(L2)2.
Antibacterial activity of ligands and their organotin(IV) complexes.
| Schiff bases/complexes | Zone of inhibition (mm) | |||||||
|---|---|---|---|---|---|---|---|---|
| Gram-negative | Gram-positive | |||||||
|
|
|
|
| |||||
| 500 ppm | 200 ppm | 500 ppm | 200 ppm | 500 ppm | 200 ppm | 500 ppm | 200 ppm | |
| L2H | 18 ± 0.6 | 15 ± 0.1 | 22 ± 0.6 | 17 ± 0.1 | 14 ± 0.2 | 12 ± 0.9 | 23 ± 0.2 | 20 ± 0.7 |
| Bu2Sn(L2)2 | 25 ± 0.7 | 22 ± 0.4 | 30 ± 0.3 | 26 ± 0.8 | 20 ± 0.7 | 18 ± 0.4 | 30 ± 0.1 | 25 ± 0.5 |
| L3H | 12 ± 0.1 | 10 ± 0.3 | 15 ± 0.1 | 13 ± 0.6 | 20 ± 0.1 | 18 ± 0.6 | 21 ± 0.5 | 18 ± 0.6 |
| Bu2Sn(L3)2 | 16 ± 0.4 | 15 ± 0.6 | 18 ± 0.5 | 16 ± 0.4 | 32 ± 0.1 | 28 ± 0.3 | 30 ± 0.2 | 27 ± 0.2 |
| L5H | 14 ± 0.3 | 12 ± 0.9 | 15 ± 0.2 | 12 ± 0.1 | 24 ± 0.6 | 20 ± 0.1 | 19 ± 0.1 | 17 ± 0.1 |
| Bu2Sn(L5)2 | 20 ± 0.5 | 18 ± 0.1 | 20 ± 0.5 | 18 ± 0.5 | 28 ± 0.3 | 23 ± 0.4 | 29 ± 0.4 | 25 ± 0.6 |
| L6H | 11 ± 0.3 | 13 ± 0.2 | 10 ± 0.1 | 8 ± 0.5 | 20 ± 0.5 | 17 ± 0.8 | 18 ± 0.6 | 15 ± 0.2 |
| Bu2Sn(L6)2 | 16 ± 0.2 | 15 ± 0.5 | 11 ± 0.8 | 10 ± 0.9 | 24 ± 0.9 | 19 ± 0.5 | 20 ± 0.1 | 18 ± 0.4 |
| Streptomycin | 28 ± 0.1 | 23 ± 0.3 | 26 ± 0.3 | 20 ± 0.5 | 26 ± 0.8 | 22 ± 0.1 | 32 ± 0.1 | 26 ± 0.3 |
| DMSO | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |